Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
*M00000112Q02*
14 February 2025
GENERAL MEETING - NOTICE AND PROXY FORM
Dear Shareholder
A General Meeting (Meeting) of shareholders of Ardiden Ltd (ABN 82 110 884 252) (Company) will be held at
The Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005 on Wednesday, 26 March 2025 at 9.30am
(AWST).
The Board has made the decision that it will hold a physical Meeting. In accordance with section 110D(1) of the
Corporations Act 2001 (Cth), the Company will not be sending hard copies of the Notice of Meeting (Notice) to
shareholders unless a shareholder has made a valid election to receive such documents in hard copy. The Notice
can be viewed and downloaded from the Company’s website at https://www.ardiden.com.au or ASX at
www.asx.com.au.
You may vote by attending the Meeting in person (or by attorney), by proxy or by appointing a corporate
representative. The Company strongly encourages shareholders to lodge a directed proxy form prior to the
Meeting. Shareholders can lodge their vote by going to www.investorvote.com.au and logging in with the meeting
ID, your unique shareholder identification number and postcode (or country for overseas residents), which you
can find on your enclosed personalised proxy form.
Your proxy form must be received by 9:30am (AWST) on Monday, 24 March 2025 being not less than 48 hours
before the commencement of the Meeting. Any proxy forms received after that time will not be valid for the
Meeting.
Shareholders may submit questions in advance of the Meeting by email to the Company Secretary at
info@ardiden.com.au by 5.00pm (AWST) on Wednesday, 19 March 2025. Shareholders who physically attend
the Meeting will also have the opportunity to submit questions during the Meeting.
If the Company makes any alternative arrangements to the way in which the meeting is held, Shareholders will be
notified by way of announcement on ASX and the details will also be made available on our website at
https://www.ardiden.com.au.
The Notice is important and should be read in its entirety. If you are in doubt as to the course of action you should
follow, you should consult your financial adviser, lawyer, accountant or other professional adviser.
If you have any difficulties obtaining a copy of the Notice, please contact the Company’s share registry,
Computershare, on 1300 850 505 (within Australia) or +61 3 9415 4000 (overseas).
The Company encourages shareholders to provide an email address so we can communicate with you
electronically for items such as notices of meeting and annual reports. Shareholders can still elect to receive
some or all of their communications in physical or electronic form, or elect not to receive certain documents such
as annual reports. To review or update your communication preferences, please contact the Company’s share
registry, Computershare, at http://www.investorcentre.com/.
Yours sincerely
Ms Tara Robson
Interim Chief Executive Officer, Chief Financial Officer and Company Secretary
Samples/000001/000002/i12
Ardiden Ltd
ABN 82 110 884 252
NOTICE OF GENERAL MEETING
AND EXPLANATORY
MEMORANDUM TO
SHAREHOLDERS
Date of Meeting
Wednesday, 26 March 2025
Time of Meeting
9:30am (AWST)
Place of Meeting
The Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005
A Proxy Form is enclosed or has otherwise been provided to you
Please read this Notice and Explanatory Memorandum carefully.
If you are unable to attend the General Meeting, please complete and return the Proxy Form in
accordance with the specified directions.
1
ARDIDEN LTD
ABN 82 110 884 252
NOTICE OF GENERAL MEETING
Notice is given that the General Meeting of Shareholders of Ardiden Ltd ABN 82 110 884 252
will be held at the Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005 on
Wednesday, 26 March 2025 at 9:30am (AWST) for the purpose of transacting the following
business referred to in this Notice of General Meeting.
The Company will update Shareholders if changing circumstances will impact the planning or
arrangements for the Meeting by way of announcement on ASX and the details will also be
made available on our website at www.ardiden.com.au.
AGENDA
1
Resolution 1 – Grant of Incentive Options to Ms Michelle Roth (Director) or her
nominee(s)
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the Directors are
authorised to issue up to 1,000,000 Incentive Options for no cash consideration, with each
Incentive Option having an exercise price of the greater of $0.20 and 143% of the VWAP of
Shares over the five Trading Days up to the date of the Meeting and an expiry date of four years
from the date of issue, to Ms Michelle Roth or her nominee(s), on the terms and conditions set
out in the Explanatory Memorandum (including Annexure A to the Explanatory Memorandum).”
Voting exclusion statement: The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a)
Ms Michelle Roth and any other person who will obtain a material benefit as a result of the issue of the securities
(except a benefit solely by reason of being a holder of ordinary securities in the entity); or
(b)
an Associate of those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b)
the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided
the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting,
and is not an Associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to
vote in that way.
Further, a Restricted Voter who is appointed as a proxy will not vote on the Resolution unless:
(a)
the appointment specifies the way the proxy is to vote on the Resolution; or
(b)
the proxy is the Chair of the Meeting and the appointment expressly authorises the Chair to exercise the proxy
even though the Resolution is connected directly or indirectly with the remuneration of a member of the Key
Management Personnel. Shareholders should note that the Chair intends to vote any undirected proxies in
favour of the Resolution.
Shareholders may also choose to direct the Chair to vote against the Resolution or to abstain from voting.
If any of the persons named above purport to cast a vote other than as permitted above, that vote will be disregarded by
the Company (as indicated above) and those persons may be liable for breaching the voting restrictions that apply to them
under the Corporations Act.
2
2
Resolution 2 – Grant of Incentive Options to Mr Jeremy Robinson (Director) or his
nominee(s)
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the Directors are
authorised to issue up to 1,000,000 Incentive Options for no cash consideration, with each
Incentive Option having an exercise price of the greater of $0.20 and 143% of the VWAP of
Shares over the five Trading Days up to the date of the Meeting and an expiry date of four years
from the date of issue, to Mr Jeremy Robinson or his nominee(s), on the terms and conditions
set out in the Explanatory Memorandum (including Annexure A to the Explanatory
Memorandum).”
Voting exclusion statement: The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a)
Mr Jeremy Robinson and any other person who will obtain a material benefit as a result of the issue of the
securities (except a benefit solely by reason of being a holder of ordinary securities in the entity); or
(b)
an Associate of those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b)
the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided
the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting,
and is not an Associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to
vote in that way.
Further, a Restricted Voter who is appointed as a proxy will not vote on the Resolution unless:
(a)
the appointment specifies the way the proxy is to vote on the Resolution; or
(b)
the proxy is the Chair of the Meeting and the appointment expressly authorises the Chair to exercise the proxy
even though the Resolution is connected directly or indirectly with the remuneration of a member of the Key
Management Personnel. Shareholders should note that the Chair intends to vote any undirected proxies in
favour of the Resolution.
Shareholders may also choose to direct the Chair to vote against the Resolution or to abstain from voting.
If any of the persons named above purport to cast a vote other than as permitted above, that vote will be disregarded by
the Company (as indicated above) and those persons may be liable for breaching the voting restrictions that apply to them
under the Corporations Act.
3
Resolution 3 – Grant of Incentive Options to Mr Douglas Jendry (Director) or his
nominee(s)
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the Directors are
authorised to issue up to 1,000,000 Incentive Options for no cash consideration, with each
Incentive Option having an exercise price of the greater of $0.20 and 143% of the VWAP of
Shares over the five Trading Days up to the date of the Meeting and an expiry date of four years
3
from the date of issue, to Mr Douglas Jendry or his nominee(s), on the terms and conditions set
out in the Explanatory Memorandum (including Annexure A to the Explanatory Memorandum).”
Voting exclusion statement: The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a)
Mr Douglas Jendry and any other person who will obtain a material benefit as a result of the issue of the securities
(except a benefit solely by reason of being a holder of ordinary securities in the entity); or
(b)
an Associate of those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b)
the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided
the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting,
and is not an Associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to
vote in that way.
Further, a Restricted Voter who is appointed as a proxy will not vote on the Resolution unless:
(a)
the appointment specifies the way the proxy is to vote on the Resolution; or
(b)
the proxy is the Chair of the Meeting and the appointment expressly authorises the Chair to exercise the proxy
even though the Resolution is connected directly or indirectly with the remuneration of a member of the Key
Management Personnel. Shareholders should note that the Chair intends to vote any undirected proxies in
favour of the Resolution.
Shareholders may also choose to direct the Chair to vote against the Resolution or to abstain from voting.
If any of the persons named above purport to cast a vote other than as permitted above, that vote will be disregarded by
the Company (as indicated above) and those persons may be liable for breaching the voting restrictions that apply to them
under the Corporations Act.
OTHER BUSINESS
To deal with any other business which may be brought forward in accordance with the
Constitution and the Corporations Act.
Details of the definitions and abbreviations used in this Notice are set out in the Glossary to the
Explanatory Memorandum.
By order of the Board
Tara Robson
Interim Chief Executive Officer, Chief Financial Officer and Company Secretary
Dated: 5 February 2025
4
connected directly or indirectly with the
remuneration of a member of the Key
Management Personnel.
How to vote
Shareholders can vote by either:
attending the Meeting and voting in person or by
attorney or, in the case of corporate Shareholders,
by appointing a corporate representative to attend
and vote; or
appointing a proxy to attend and vote on their
behalf using the Proxy Form accompanying this
Notice of Meeting and by submitting their proxy
appointment and voting instructions in person, by
post, electronically via the internet or by facsimile.
Should any resolution, other than those specified
in this Notice, be proposed at the Meeting, a proxy
may vote on that resolution as they think fit.
If a proxy is instructed to abstain from voting on an
item of business, they are directed not to vote on
the Shareholder's behalf on the poll and the
Shares that are the subject of the proxy
appointment will not be counted in calculating the
required majority.
Shareholders who return their Proxy Forms with a
direction how to vote, but who do not nominate the
identity of their proxy, will be taken to have
appointed the Chair of the Meeting as their proxy
to vote on their behalf. If a Proxy Form is returned
but the nominated proxy does not attend the
Meeting, the Chair of the Meeting will act in place
of the nominated proxy and vote in accordance
with any instructions. Proxy appointments in favour
of the Chair of the Meeting, the secretary or any
Director that do not contain a direction how to vote
will be used, where possible, to support each of
the Resolutions proposed in this Notice, provided
they are entitled to cast votes as a proxy under the
voting exclusion rules which apply to some of the
proposed Resolutions. These rules are explained
in this Notice.
To be effective, proxies must be received by
9:30am (AWST) on Monday, 24 March 2025.
Proxies received after this time will be invalid.
Proxies may be lodged using any of the following
methods:
By internet:
Voting in person (or by attorney)
Shareholders, or their attorneys, who plan to attend the
Meeting are asked to arrive at the venue 15 minutes prior
to the time designated for the Meeting, if possible, so that
their holding may be checked against the Company's
share register and their attendance recorded. To be
effective a certified copy of the Power of Attorney, or the
original Power of Attorney, must be received by the
Company in the same manner, and by the same time as
outlined for proxy forms below.
Voting by a Corporation
A Shareholder that is a corporation may appoint an
individual to act as its representative and vote in person at
the Meeting. The appointment must comply with the
requirements of section 250D of the Corporations Act. The
representative should bring to the Meeting evidence of his
or her appointment, including any authority under which it
is signed.
Voting by proxy
A Shareholder entitled to attend and vote is
entitled to appoint not more than two proxies. Each
proxy will have the right to vote on a poll and also
to speak at the Meeting.
The appointment of the proxy may specify the
proportion or the number of votes that the proxy
may exercise. Where more than one proxy is
appointed and the appointment does not specify
the proportion or number of the Shareholder's
votes each proxy may exercise, the votes will be
divided equally among the proxies (i.e. where
there are two proxies, each proxy may exercise
half of the votes).
A proxy need not be a Shareholder.
The proxy can be either an individual or a body
corporate.
If a proxy is not directed how to vote on an item of
business, the proxy may generally vote, or abstain
from voting, as they think fit. However, where a
Restricted Voter is appointed as a proxy, the proxy
may only vote on Resolutions 1 to 3 (inclusive) in
accordance with a direction on how the proxy is to
vote or, if the proxy is the Chair of the Meeting and
the appointment expressly authorises the Chair to
exercise the proxy even if the Resolution is
Log on to www.investorvote.com.au. If you
are a custodian and an Intermediary
Online subscriber, you can log on to
www.intermediaryonline.com.
By post:
Computershare Investor Services Pty
Limited, GPO Box 242, Melbourne Victoria
3001 Australia.
By fax:
(within Australia) 1800 783 447
(outside Australia) +61 3 9473 2555
The Proxy Form must be signed by the
Shareholder or the Shareholder's attorney. Proxies
given by corporations must be executed in
accordance with the Corporations Act. Where the
appointment of a proxy is signed by the appointer's
attorney, a certified copy of the Power of Attorney,
or the power itself, must be received by the
Company at the above address, or by facsimile,
and by 9:30am (AWST) on Monday, 24 March
5
2025. If facsimile transmission is used, the Power
of Attorney must be certified.
Shareholders who are entitled to vote
In accordance with paragraphs 7.11.37 and 7.11.38 of the
Corporations Regulations, the Board has determined that
a person's entitlement to vote at the General Meeting will
be the entitlement of that person set out in the Register of
Shareholders as at 4:00pm (AWST) on Monday, 24 March
2025.
6
ARDIDEN LTD
ABN 82 110 884 252
EXPLANATORY MEMORANDUM
This Explanatory Memorandum is intended to provide Shareholders with sufficient information to
assess the merits of the Resolutions contained in the accompanying Notice of General Meeting of the
Company.
Certain abbreviations and other defined terms are used throughout this Explanatory Memorandum.
Defined terms are generally identifiable by the use of an upper case first letter. Details of the
definitions and abbreviations are set out in the Glossary to the Explanatory Memorandum.
1
Resolutions 1 to 3 (inclusive) – Grant of Incentive Options to the Participating Directors
or their nominee(s)
1.1
Background
Subject to Shareholder approval under Resolutions 1 to 3 (inclusive), the Company proposes to grant
a total of up to 3,000,000 Options (each with an exercise price of the greater of $0.20 and 143% of
the VWAP of Shares over the five Trading Days up to the date of the Meeting and an expiry date of
four years from the date of issue), on the terms detailed in Annexure A (Incentive Options), to NonExecutive Chair Ms Michelle Roth, Non-Executive Director Mr Jeremy Robinson, and Non-Executive
Director Mr Douglas Jendry (Participating Directors), or their nominee(s), as follows:
up to 1,000,000 Incentive Options to Ms Roth or her nominee(s) (the subject of Resolution 1);
up to 1,000,000 Incentive Options to Mr Robinson or his nominee(s) (the subject of Resolution
2); and
up to 1,000,000 Incentive Options to Mr Jendry or his nominee(s) (the subject of Resolution 3).
Refer to Annexure A of this Explanatory Memorandum for the terms of the Incentive Options.
Under the Company’s current circumstances, the Directors (in the absence of the Participating
Directors regarding each of their respective Resolutions) consider that the grant of Incentive Options
represents a cost-effective way for the Company to remunerate the Participating Directors, as
opposed to cash remuneration. The Incentive Options are not considered to constitute a material
personal interest for any of the Participating Directors.
The number of Incentive Options to be granted to each of the Participating Directors has been
determined (in the absence of the Participating Directors regarding each of their respective
Resolutions) based upon a consideration of:
the remuneration of the Participating Directors;
the extensive experience and reputation of the Participating Directors within the mining
industry;
the current price of Shares;
the Directors’ wish to ensure that the remuneration offered is competitive with market standards
and practice. The Directors have considered the proposed number of Incentive Options to be
granted and will ensure that the Participating Directors’ overall remuneration is in line with
market practice;
attracting and retaining suitably qualified non-executive directors; and
7
incentives to attract and ensure continuity of service of Directors who have appropriate
knowledge and expertise, while maintaining the Company’s cash reserves.
The Company does not consider that there are any significant opportunity costs to the Company or
benefits foregone by the Company in issuing the Incentive Options upon the terms proposed.
Resolutions 1 to 3 (inclusive) seek Shareholder approval for the purposes of Listing Rule 10.11 and
for all other purposes to grant Incentive Options to the Participating Directors, as set out above.
1.2
Related Party Transactions Generally
Chapter 2E of the Corporations Act prohibits a public company from giving a financial benefit to a
related party of the public company unless either:
the giving of the financial benefits falls within one of the nominated exceptions to the provision;
or
Shareholder approval is obtained prior to the giving of the financial benefit and the benefit is
given within 15 months after obtaining such approval.
For the purposes of Chapter 2E of the Corporations Act, each of the Participating Directors is a
related party of the Company.
In relation to Resolutions 1 to 3 (inclusive), the Board (in the absence of the Participating Directors
regarding each of their respective Resolutions) has formed the view that Shareholder approval under
section 208 of the Corporations Act is not required for the proposed issue of Incentive Options, on the
basis that the issue of Incentive Options is considered by the Board (in the absence of the
Participating Directors regarding each of their respective Resolutions) to constitute reasonable
remuneration and, therefore, the exception in section 211 of the Corporations Act applies to the
Resolutions. Section 211 provides that Shareholder approval is not required for the purposes of
section 208 in circumstances where the benefit constitutes remuneration which would be reasonable
given the Company’s and the related party’s circumstances.
1.3
Total remuneration package
The Participating Directors’ fees per annum (including superannuation) and the total financial benefit
to be received by them in this current period, as a result of the grant of the Incentive Options the
subject of the Resolutions, are as follows:
Director
Fees p.a.
($)
Value of Incentive
Options ($)
Total Financial
Benefit ($)
Ms Michelle Roth
85,000
54,000
139,000
Mr Jeremy Robinson
65,000
54,000
119,000
Mr Douglas Jendry
65,000
54,000
119,000
The indicative valuation of $0.0540 per Incentive Option is a theoretical valuation of each Incentive
Option using the Black – Scholes Model per section 1.4 below.
1.4
Valuation of Incentive Options
The Company's advisers have valued the Incentive Options proposed to be granted to the
Participating Directors using the Black – Scholes Model. The value of an option or right calculated by
the Black – Scholes Model is a function of a number of variables. The valuation of the Incentive
8
Options has been prepared using the following assumptions (as at 3 February 2025, being the last
practicable date prior to dispatch of the Notice):
Variable
Input
Share price
$0.1422
Exercise price
$0.21
Risk Free Interest Rate
3.75%
Volatility
59%
Time (years to expiry)
4 years
Value per Incentive Option
$0.0540
Any change in the variables applied in the Black – Scholes calculation above between the date of the
valuation and the date the Incentive Options are granted would have an impact on their value.
Based on the assumptions above, it is considered that the estimated average value of the Incentive
Options proposed to be granted to the Participating Directors is $0.0540 per Incentive Option.
1.5
Directors’ Recommendation
ASIC Regulatory Guide 76: Related Party Transactions notes at Table 2 of paragraph 76.104 that it is
good practice for directors to avoid making a recommendation for resolutions about each other’s
remuneration. The Directors have declined to make a recommendation about Resolutions 1 to 3
(inclusive) in line with the ASIC guidance.
The Board is not aware of any other information that would reasonably be required by the
Shareholders to allow them to make a decision whether it is in the best interests of the Company to
pass the Resolutions.
1.6
Information Requirements – Listing Rules 10.11 and 10.13
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, the
Company must not issue or agree to issue Equity Securities to:
a related party (Listing Rule 10.11.1);
a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial (30%+) holder in the Company (Listing Rule 10.11.2);
a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial (10%+) holder in the Company and who has nominated a Director to the Board
pursuant to a relevant agreement which gives them a right or expectation to do so (Listing Rule
10.11.3);
an Associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing Rule 10.11.4);
or
a person whose relationship with the Company or a person referred to in Listing Rules 10.11.1
to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by
Shareholders (Listing Rule 10.11.5),
unless it obtains the approval of its Shareholders.
9
The proposed grant of Incentive Options to the Participating Directors pursuant to the Resolutions
falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It
therefore requires the approval of Shareholders under and for the purposes of Listing Rule 10.11.
If Resolution 1 is passed, the Company will grant Incentive Options to Ms Roth or her nominee(s), as
noted above.
If Resolution 1 is not passed, the Company will not grant Incentive Options to Ms Roth or her
nominee(s) and the Company may need to consider alternative ways to remunerate Ms Roth,
including by the payment of cash.
If Resolution 2 is passed, the Company will grant Incentive Options to Mr Robinson or his nominee(s),
as noted above.
If Resolution 2 is not passed, the Company will not grant Incentive Options to Mr Robinson or his
nominee(s) and the Company may need to consider alternative ways to remunerate Mr Robinson,
including by the payment of cash.
If Resolution 3 (inclusive) is passed, the Company will grant Incentive Options to Mr Jendry or his
nominee(s), as noted above.
If Resolution 3 (inclusive) is not passed, the Company will not grant Incentive Options to Mr Jendry or
his nominee(s) and the Company may need to consider alternative ways to remunerate Mr Jendry,
including by the payment of cash.
The following further information is provided to Shareholders for the purposes of Listing Rule 10.13:
the Incentive Options will be granted to the Participating Directors or their nominees, as noted
above;
Ms Roth, Mr Robinson and Mr Jendry are Directors and therefore fall under Listing Rule
10.11.1;
up to a total of 3,000,000 Incentive Options will be granted to the Participating Directors as
follows:
(i)
up to 1,000,000 Incentive Options to Ms Roth or her nominee(s) (the subject of
Resolution 1);
(ii)
up to 1,000,000 Incentive Options to Mr Robinson or his nominee(s) (the subject of
Resolution 2); and
(iii)
up to 1,000,000 Incentive Options to Mr Jendry or his nominee(s) (the subject of
Resolution 3);
the material terms and conditions of the Incentive Options are set out in Annexure A to this
Explanatory Memorandum;
the Incentive Options will be granted on a date which will be no later than 1 month after the
date of this Meeting, unless otherwise extended by way of ASX granting a waiver to the Listing
Rules;
the Incentive Options will be granted for no cash consideration;
the purpose of the proposed issue of Incentive Options is to remunerate the Participating
Directors, as noted above. No funds will be raised from the grant of the Incentive Options. The
funds raised from the exercise of the Incentive Options are intended to be used for general
working capital. As the Company has no specific use of the funds in mind given the uncertainty
10
of timing or receipt of the funds, the funds will be spent in line with the Company’s goals as
announced to ASX at the time the funds become available;
Ms Roth, Mr Robinson and Mr Jendry are each a Director of the Company and
Share your feedback
Discover